Infrastructure Capital Advisors LLC Sells 83,758 Shares of Kenvue Inc. $KVUE

Infrastructure Capital Advisors LLC reduced its stake in shares of Kenvue Inc. (NYSE:KVUE) by 61.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,501 shares of the company’s stock after selling 83,758 shares during the quarter. Infrastructure Capital Advisors LLC’s holdings in Kenvue were worth $905,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Kenvue in the 2nd quarter valued at approximately $6,528,000. Jump Financial LLC grew its holdings in Kenvue by 210.6% during the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after purchasing an additional 37,170 shares during the period. AXA S.A. grew its holdings in Kenvue by 21.1% during the second quarter. AXA S.A. now owns 48,892 shares of the company’s stock valued at $1,023,000 after purchasing an additional 8,524 shares during the period. NewEdge Advisors LLC increased its stake in Kenvue by 219.1% in the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after purchasing an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company increased its stake in Kenvue by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock valued at $39,217,000 after purchasing an additional 10,885 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 1.59% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on KVUE shares. Wall Street Zen upgraded shares of Kenvue to a “buy” rating in a report on Sunday, July 12th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, June 15th. Citigroup lowered their price objective on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Zacks Research downgraded Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Finally, UBS Group lifted their target price on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, July 16th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to data from MarketBeat, Kenvue currently has an average rating of “Hold” and a consensus target price of $19.58.

Kenvue Price Performance

NYSE KVUE opened at $19.43 on Tuesday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The stock has a market cap of $37.32 billion, a price-to-earnings ratio of 22.86, a PEG ratio of 1.46 and a beta of 0.47. The business has a 50 day simple moving average of $18.42 and a 200 day simple moving average of $17.94. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $22.74.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. The firm had revenue of $3.91 billion for the quarter, compared to analyst estimates of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The business’s revenue was up 4.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.24 earnings per share. Analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were issued a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.3%. The ex-dividend date was Wednesday, May 13th. Kenvue’s dividend payout ratio (DPR) is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.